Nicholas Willumsen
9PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 05, 2024
Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.Christina Jensen, Simone Maarup, Hans Skovgaard Poulsen
|Dec 01, 2022
Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.Troels D Christensen, Christina Jensen, Ole Larsen
|Mar 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.Nicholas Willumsen, Christina Jensen, George Green
|Mar 09, 2021
Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma.Neel Ingemann Nissen, Stephanie Kehlet, Astrid Z Johansen
|Jan 22, 2021
Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa.Song Wang, Cecilie L Bager, Morten A Karsdal
|Oct 24, 2019
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.Inna M Chen, Nicholas Willumsen, Christian Dehlendorff
Pageof 2
